Namenda (memantine) is indicated for which stage of Alzheimer's disease?

Enhance your preparation for the PMHNP Certification Exam with Georgette's resources. Delve into multiple-choice questions and detailed explanations to ensure you're ready for success. Boost your study efficiency and exam confidence today!

Multiple Choice

Namenda (memantine) is indicated for which stage of Alzheimer's disease?

Explanation:
Memantine is approved for the symptoms of Alzheimer's disease in the later stages because it helps modulate glutamate activity in the brain, which becomes more problematic as the disease progresses. This results in modest improvements or stabilization in cognition and daily function during the moderate to severe stage, and it can be used alone or with a cholinesterase inhibitor like donepezil for added effect in that stage. It is not indicated for mild cognitive impairment or preclinical stages, and it isn’t considered beneficial across all stages equally, since evidence supports its use mainly in moderate to severe dementia.

Memantine is approved for the symptoms of Alzheimer's disease in the later stages because it helps modulate glutamate activity in the brain, which becomes more problematic as the disease progresses. This results in modest improvements or stabilization in cognition and daily function during the moderate to severe stage, and it can be used alone or with a cholinesterase inhibitor like donepezil for added effect in that stage. It is not indicated for mild cognitive impairment or preclinical stages, and it isn’t considered beneficial across all stages equally, since evidence supports its use mainly in moderate to severe dementia.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy